Shares of Cardiovascular Systems, Inc. (NASDAQ:CSII) have been assigned a consensus recommendation of “Hold” from the eight ratings firms that are covering the company, Marketbeat.com reports. Two equities research analysts have rated the stock with a sell recommendation, three have assigned a hold recommendation and two have given a buy recommendation to the company. The average 1 year price objective among analysts that have covered the stock in the last year is $38.00.

A number of brokerages have recently issued reports on CSII. BidaskClub downgraded Cardiovascular Systems from a “sell” rating to a “strong sell” rating in a research report on Friday, August 18th. Needham & Company LLC reiterated a “buy” rating and set a $36.00 price target (down previously from $37.00) on shares of Cardiovascular Systems in a research report on Thursday, October 26th. Zacks Investment Research downgraded Cardiovascular Systems from a “hold” rating to a “sell” rating in a research report on Tuesday, October 10th. Raymond James Financial reiterated a “hold” rating on shares of Cardiovascular Systems in a research report on Monday, December 4th. Finally, Citigroup began coverage on Cardiovascular Systems in a research report on Thursday, September 21st. They set a “market perform” rating for the company.

Cardiovascular Systems (NASDAQ CSII) opened at $24.47 on Monday. Cardiovascular Systems has a 12 month low of $23.00 and a 12 month high of $33.11. The company has a quick ratio of 3.83, a current ratio of 4.30 and a debt-to-equity ratio of 0.18. The company has a market capitalization of $834.97, a PE ratio of 1,223.50 and a beta of 2.52.

Cardiovascular Systems (NASDAQ:CSII) last issued its earnings results on Wednesday, October 25th. The medical device company reported ($0.06) EPS for the quarter, topping the consensus estimate of ($0.08) by $0.02. Cardiovascular Systems had a positive return on equity of 0.74% and a negative net margin of 0.93%. The business had revenue of $49.70 million during the quarter, compared to the consensus estimate of $51.00 million. During the same quarter last year, the company earned ($0.06) EPS. The firm’s revenue was down .2% compared to the same quarter last year. equities analysts expect that Cardiovascular Systems will post -0.05 earnings per share for the current year.

Several hedge funds and other institutional investors have recently made changes to their positions in the stock. Sterling Capital Management LLC raised its holdings in shares of Cardiovascular Systems by 15.8% during the 3rd quarter. Sterling Capital Management LLC now owns 59,527 shares of the medical device company’s stock valued at $1,676,000 after buying an additional 8,122 shares in the last quarter. Point72 Asset Management L.P. raised its holdings in shares of Cardiovascular Systems by 132.7% during the 3rd quarter. Point72 Asset Management L.P. now owns 469,978 shares of the medical device company’s stock valued at $13,230,000 after buying an additional 267,988 shares in the last quarter. Granahan Investment Management Inc. MA raised its holdings in shares of Cardiovascular Systems by 6.8% during the 3rd quarter. Granahan Investment Management Inc. MA now owns 306,058 shares of the medical device company’s stock valued at $8,616,000 after buying an additional 19,398 shares in the last quarter. Wells Fargo & Company MN raised its holdings in shares of Cardiovascular Systems by 8.4% during the 3rd quarter. Wells Fargo & Company MN now owns 47,253 shares of the medical device company’s stock valued at $1,330,000 after buying an additional 3,648 shares in the last quarter. Finally, Trexquant Investment LP purchased a new position in shares of Cardiovascular Systems during the 3rd quarter valued at about $276,000. 75.05% of the stock is currently owned by institutional investors.

ILLEGAL ACTIVITY WARNING: “Cardiovascular Systems, Inc. (CSII) Receives Consensus Rating of “Hold” from Brokerages” was first posted by American Banking News and is the sole property of of American Banking News. If you are viewing this news story on another publication, it was illegally stolen and reposted in violation of US and international copyright and trademark law. The correct version of this news story can be viewed at https://www.americanbankingnews.com/2017/12/11/cardiovascular-systems-inc-csii-receives-consensus-rating-of-hold-from-brokerages.html.

About Cardiovascular Systems

Cardiovascular Systems, Inc is a medical technology company. The Company is engaged in treating patients suffering from peripheral and coronary artery diseases, including those with arterial calcium. The Company develops an orbital atherectomy technology for both peripheral and coronary commercial applications.

Analyst Recommendations for Cardiovascular Systems (NASDAQ:CSII)

Receive News & Ratings for Cardiovascular Systems Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardiovascular Systems Inc. and related companies with MarketBeat.com's FREE daily email newsletter.